Last week I questioned whether Australia had backed the wrong vaccine, given research suggested that AstraZeneca was more effective against the Delta strain than Pfizer.
A new study analysing COVID-19 related outcomes from Bahrain between December 2020 and July 2021 shows that recipients of the AstraZeneca vaccine were hospitalised less and experienced less death than recipients of three other vaccines – Pfizer, Sinopharm and Sputnik.
Below is a summary of this study:
There are 1171 words left in this subscriber-only article.
Start your free 14-day trial today!
Just 1.52 per cent of people who got two doses of the Oxford-made vaccine were admitted to wards after they caught the virus, researchers said. And only 0.03 per cent, or one in 3,000, died from the disease.
But among those who got the Pfizer vaccine 1.99 per cent were hospitalised and 0.15 per cent died after they were infected with the virus…
‘All four vaccines decreased the risk of coronavirus infections, hospitalisations, ICU admissions and deaths when compared to unvaccinated individuals.’
‘AstraZeneca and Pfizer provide good protection.’
Again, the differing situations facing the UK – which primarily used AstraZeneca – and Israel – which used Pfizer – supports the above findings.
Both nations has very high vaccination rates:
Cases have surged more in Israel:
Hospitalisations are worse in Israel:
As are COVID deaths:
Israel has begun giving booster (third) vaccines for residents aged 60 and above, with the government approving booster shots to everyone aged 40 and above.
Givens Australians have chosen Pfizer, are we looking at similar outcomes when we eventually open?